NASDAQ:UNCY
Unicycive Therapeutics, Inc. Stock Company Profile
$1.12
+0 (+0%)
At Close: May 03, 2024
Information
4300 El Camino Real, Suite 210
Los Altos CA 94022
650 351 4495
www.unicycive.com
Industry: Biotechnology
Sector: Healthcare
Description
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.